Physician treatment decisions for hormone receptor-positive, HER2-negative early breast cancer in young patients: a Latin American survey

Simple item page
dc.contributor.authorDana Narváez
dc.contributor.authorFederico Waisberg
dc.contributor.authorCynthia Villarreal‐Garza
dc.contributor.authorSergio Rivero
dc.contributor.authorCristian Alexis Ostinelli
dc.contributor.authorMatías Chacón
dc.contributor.authorFrancisco Ojeda
dc.contributor.authorAlvaro Encinas Casanave
dc.contributor.authorMaría Lucila González Donna
dc.contributor.authorCinthia Gauna
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:47:00Z
dc.date.available2026-03-22T19:47:00Z
dc.date.issued2025
dc.description.abstractThis study highlights considerable variability in the management of young women with HR+ early breast cancer across Latin America. Physician gender, specialty, and resource availability significantly influence treatment decisions. These findings underscore the urgent need for regionally tailored clinical guidelines and improved access to diagnostic and supportive care resources to ensure equitable and evidence-based care.
dc.identifier.doi10.1177/17588359251384846
dc.identifier.urihttps://doi.org/10.1177/17588359251384846
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/78091
dc.language.isoen
dc.publisherSAGE Publishing
dc.relation.ispartofTherapeutic Advances in Medical Oncology
dc.sourceInstituto Alexander Fleming
dc.subjectMedicine
dc.subjectLatin Americans
dc.subjectFamily medicine
dc.subjectBreast cancer
dc.subjectCancer
dc.subjectPatient care
dc.subjectGynecology
dc.subjectMEDLINE
dc.subjectHormone therapy
dc.subjectHormone replacement therapy (female-to-male)
dc.titlePhysician treatment decisions for hormone receptor-positive, HER2-negative early breast cancer in young patients: a Latin American survey
dc.typearticle

Files

Collections

Artículo Científico Publicado